The table below shows Cytosorbents Corp's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$37.06M
$35.59M
$31.08M
$34.69M
$43.17M
$41.00M
Cost of revenue
$10.57M
$10.71M
$9.13M
$13.96M
$11.05M
$11.05M
Gross profit
$26.49M
$24.89M
$21.95M
$20.73M
$32.12M
$29.95M
R&D
-
-
$15.73M
$15.12M
$16.38M
$8.81M
SG&A
CTSO annual revenue (10-K history)
Cytosorbents Corp reported annual revenue of $37.06M for fiscal year 2025. That is up 4.1% from $35.59M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $9.53M (FY 2016) to $37.06M. Figures come from the company's audited annual reports as filed with the SEC.